Loading asset research
Citius Oncology Inc. Common Stock
CTORNasdaq · USD · StocksQuote as of · Exchange session not verified$0.918
+0.88%
Today
CTOR
Loading 1D prices…
Market cap
$97M
Volume
138.3K
52w high
$2.2552w low
$0.491Company profile
Citius Oncology Inc. Common Stock
Citius Oncology, Inc. focuses on the development and commercialization of targeted oncology therapies. It also engages in the development of LYMPHIR, an orphan indication for the treatment of adult patients with relapsed or refractory cutaneous T-cell lymphoma, a rare form of non-Hodgkin lymphoma. The company is headquartered in Cranford, New Jersey. Citius Oncology, Inc. operates as a subsidiary of Leonard-Meron Biosciences, Inc.
Sector
Health Care
Industry
Pharmaceutical Preparations
Exchange
Nasdaq
Display currency
USD
Location
Cranford, NJ, United States
Fiscal year end
0930
CIK
1851484
Session & valuation
Open$0.89
Previous close$0.91
Day high$0.95
Day low$0.89
30-day avg. volume109.6K
Outstanding shares93M
Diluted EPS-$0.42
Latest annual period
P/E (trailing)-2.19
P/E (forward)—
Price / book2.40
Beta3.53
Dividend yield—
Deterministic peer set
Companies with SEC SIC 2834
Exact regulatory industry matches, ranked by nearest market capitalization.
| Company | Market cap | Revenue | Net margin | Diluted EPS | Today | Consensus |
|---|---|---|---|---|---|---|
| ANIXAnixa Biosciences Inc. Common Stock | $95.9M | $0.00 | — | -$0.23 | +1.82% | Buy |
| CPIXCumberland Pharmaceuticals Inc. Common Stock | $95.7M | $44.5M | -6.37% | -$0.19 | -1.39% | Unrated |
| ONCYOncolytics Biotech Inc. Common Stock | $95.1M | $0.00 | — | -$0.30 | -2.74% | Buy |
| PLYXPolaryx Therapeutics Inc. Common Stock | $100.2M | $0.00 | — | -$0.20 | +1.01% | Buy |
| COYACoya Therapeutics Inc. Common Stock | $102.7M | $7.9M | -267.14% | -$1.27 | -3.10% | Buy |